News Spark files revolutionary gene therapy with FDA Luxturna granted six-month priority review by FDA.
News Disappointment as government delays pharma-friendly policies Proposals fall short of ambitions of Accelerated Access Review.
News Amicus to file Fabry drug after FDA changes mind Regulator drops demand for further phase 3 trial.
News The curious case of Mylotarg: Pfizer's leukaemia drug set to... Mylotarg backed by advisers after withdrawal in 2010.
Events Partner Content Clinical Trial Supply East Coast 2017 The 15th Annual CTS East Coast event builds on last year’s conference, Arena’s biggest East Coast CTS event to date.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
